Suppr超能文献

基于细胞因子的对数标度扩增功能性小鼠树突状细胞。

Cytokine-based log-scale expansion of functional murine dendritic cells.

机构信息

Department of Gene Therapy, Chiba University Graduate School of Medicine, Chiba, Japan.

出版信息

PLoS One. 2009 Aug 18;4(8):e6674. doi: 10.1371/journal.pone.0006674.

Abstract

BACKGROUND

Limitations of the clinical efficacy of dendritic cell (DC)-based immunotherapy, as well as difficulties in their industrial production, are largely related to the limited number of autologous DCs from each patient. We here established a possible breakthrough, a simple and cytokine-based culture method to realize a log-scale order of functional murine DCs (>1,000-fold), which cells were used as a model before moving to human studies.

METHODOLOGY/PRINCIPAL FINDINGS: Floating cultivation of lineage-negative hematopoietic progenitors from bone marrow in an optimized cytokine cocktail (FLT3-L, IL-3, IL-6, and SCF) led to a stable log-scale proliferation of these cells, and a subsequent differentiation study using IL-4/GM-CSF revealed that 3-weeks of expansion was optimal to produce CD11b+/CD11c+ DC-like cells. The expanded DCs had typical features of conventional myeloid DCs in vitro and in vivo, including identical efficacy as tumor vaccines.

CONCLUSIONS/SIGNIFICANCE: The concept of DC expansion should make a significant contribution to the progress of DC-based immunotherapy.

摘要

背景

树突状细胞(DC)为基础的免疫疗法的临床疗效有限,其工业化生产也存在困难,这在很大程度上与每个患者自身来源的 DC 数量有限有关。我们在这里建立了一个可能的突破,即一种简单的基于细胞因子的培养方法,以实现功能性鼠源性 DC 的对数级数量级(>1000 倍),然后再将其用于人体研究。

方法/主要发现:从骨髓中分离出的谱系阴性造血祖细胞在优化的细胞因子鸡尾酒(FLT3-L、IL-3、IL-6 和 SCF)中进行悬浮培养,导致这些细胞的稳定对数级增殖,随后使用 IL-4/GM-CSF 进行的分化研究表明,3 周的扩增时间最适合产生 CD11b+/CD11c+ 类 DC 样细胞。扩增的 DC 具有体外和体内典型的常规髓样 DC 特征,包括作为肿瘤疫苗的相同功效。

结论/意义:DC 扩增的概念应该为 DC 为基础的免疫疗法的进展做出重大贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b73/2723913/b78969ec02f1/pone.0006674.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验